Related Experiment Videos
Different susceptibilities of cultured mouse cell lines to mouse interferon
Abstract:
Cultured mouse cells were treated with 3.3 approximately 10,000 units of mouse interferononon for 3 days and further cultivated in fresh medium for 2 days (recovery incubation). The IC50 (concentration of drug required for 50% inhibition) of interferon was not changed much after the recovery incubation. The most susceptible cell line to interferon was B16 melanoma; the IC50 was 10.5 units per ml of medium on day 3 after the start of treatment. P388 leukemic cells, Lewis lung carcinoma cells, and colon adenocarcinoma 38 cells were moderately susceptible to interferon and the IC50s of these cell lines were 200, 80, and 180 units per ml medium, respectively, on day 3. The cells least susceptible to interferon were those of colon adenocarcinoma 26; IC50 was greater than 10,000 units per ml. In the recovery incubation, the growth of B16 melanoma cells, P388 leukemic cells, Lewis lung carcinoma cells and colon adenocarcinoma 38 cells was considerably inhibited when these cells were treated with more than 100 approximately, 1,000 units of interferon per ml medium. The rate of multiplication was usually more than 1 for these cell lines, except for Lewis lung carcinoma cells where the rate of multiplication was less than 1. This indicates that interferon is not cytocidal towards B16 melanoma cells, P388 leukemic cells, or colon adenocarcinoma 38 cells, but mouse interfer is cytocidal towards Lewis lung carcinoma cells when the cells are treated with a relatively high concentration of interferon and then cultured in the medium without interferon.
Insights
Mouse interferon exhibits varying efficacy across different cancer cell lines. While generally not cytocidal, it proved lethal to Lewis lung carcinoma cells at high concentrations, indicating potential therapeutic applications.
Area of Science:
- Immunology
- Cancer Biology
- Pharmacology
Background:
- Interferons (IFNs) are crucial cytokines in the immune response.
- Understanding IFN sensitivity in various cancer cells is vital for therapeutic development.
- Mouse interferon's effects on different tumor cell lines require detailed characterization.
Purpose of the Study:
- To determine the dose-dependent effects of mouse interferon on the proliferation of cultured mouse cancer cell lines.
- To assess the cytocidal or cytostatic potential of mouse interferon across different cell types.
- To evaluate the impact of recovery incubation on interferon's efficacy.
Main Methods:
- Cultured mouse cell lines (B16 melanoma, P388, Lewis lung carcinoma, colon adenocarcinoma 38, colon adenocarcinoma 26) were treated with mouse interferon.
- Median inhibitory concentration (IC50) was determined after 3 days of treatment.
- Cells underwent a 2-day recovery incubation period to assess sustained effects.
- Cell proliferation rates were monitored during recovery.
Main Results:
- B16 melanoma cells were most susceptible (IC50 = 10.5 units/mL).
- P388, Lewis lung carcinoma, and colon adenocarcinoma 38 cells showed moderate susceptibility (IC50s = 200, 80, 180 units/mL, respectively).
- Colon adenocarcinoma 26 cells were least susceptible (IC50 > 10,000 units/mL).
- Mouse interferon was cytocidal to Lewis lung carcinoma cells at high concentrations post-treatment, but not cytocidal to other tested cell lines.
Conclusions:
- Mouse interferon exhibits differential sensitivity across various murine cancer cell lines.
- Lewis lung carcinoma cells demonstrated sensitivity to mouse interferon, showing cytocidal effects at higher concentrations.
- Further research into interferon's therapeutic potential against specific cancers is warranted.